Chemoimmunotherapy for relapsed/refractory Mature B-Cell Non-Hodgkin Lymphoma (B-NHL) in Children (SPARKLE Trial): Initial Safety, PK, and Efficacy

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

6-2019

DOI

10.1002/hon.27_2629

Journal Title

Hematalogical Oncology

Department

Pediatrics

Second Department

Health Behavior and Community Health

This document is currently not available here.

Share

COinS